Drawing for NOVA BIOMEDICAL

USPTO serial 99429556

NOVA BIOMEDICAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KENNEDY, LAURA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with NOVA BIOMEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sara Bauer

Sara Bauer Womble Bond Dickinson (US) LLP470 Atlantic Avenue, Suite 600Independence WharfBoston, MA 02210

Goods and services

ClassDescriptionStatusFirst use
001Calibration and quality control fluids for osmometers; calibration and quality control fluids for cryoscopes; calibration and quality control fluids for bilirubinometers for diagnostic, scientific, and research purposes; calibration and quality control fluids for fluorometers; catalysts for use in the cultivation of anaerobic bacteria; reagents used for counting cells in body fluids in the field of hematology for non-medical purposes; laboratory reagents for research and evaluation purposes for staining raw milk cells; laboratory reagents for the preservation of bulk tank and individual cow milk samples for non-medical testing; enzymes, namely, alkaline phosphatases for preservation of bulk tank and individual cow milk samples for non-medical testing; Catalysts for use in the cultivation of anaerobic bacteria for medical useACTIVE—
005Medical diagnostic reagents for the analysis of body fluids, namely, for counting cells in body fluids and in the field of hematology; biocides for the preservation of bulk tank and individual cow milk samples for laboratory testingACTIVE—
009Laboratory equipment, namely, osmometers for non-medical purposes; laboratory equipment, namely, cryoscopies for non medical purposes; laboratory equipment, namely, bilirubinometers for non-medical purposes; laboratory equipment, namely, fluorometers for non-medical purposes; laboratory equipment, namely, cell counters; laboratory equipment, namely, apparatus for cultivation of bacteria; laboratory equipment, namely, programmable fluid dispensers for use in the field of depositing samples containing microbes onto plates; laboratory diagnostic equipment, namely, assay plates, cartridges for holding laboratory samples, petri dishes, pipets, tubes, specimen transport containers, anaerobic jars and coagulation timers; downloadable software for scientific instruments and apparatus for verifying the calibration of liquid delivery and for measuring the light absorption properties of liquids; medical apparatus and instruments for use in biopharmaceutical cell line development and analysis; scientific, photographic, optical, measuring, and counting apparatus and instruments, namely, biological microscopes; apparatus for recording, transmission, or reproduction of images, namely, cell analyzer devices; computers incorporated into and used with a cell analyzer device; downloadable and recorded computer software for use in biopharmaceutical cell line development and analysis; scientific research and laboratory apparatus, namely, biological microscopes; incubators for bacteria cultures and laboratory usesACTIVE—
010Incubators for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Sep 30, 2026CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Sep 25, 2026APETASSIGNED TO PETITION STAFF—
Aug 17, 2026EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 1, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 7, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Mar 13, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 13, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 13, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 24, 2026DOCKASSIGNED TO EXAMINER—
Oct 6, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 6, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 6, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance